PTPRC and neoplasm: Whereas anti-CD45 alone only offers staining of immune cells, the combination of anti-CD29, anti-CD98, and anti-CD45 antibodies for barcoding is a potentially novel strategy that allows for the staining of mouse immune and tumor cells in any given sample.